Risk of mood disorders after epilepsy diagnosis: A nationwide retrospective cohort study in South Korea
The International Journal of Psychiatry in Medicine · 2025
DOI: 10.1177/00912174251336045 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The International Journal of Psychiatry in Medicine, 2025. Verfasst von Youngoh Bae und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Korean Armed Forces Capital Hospital, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Epilepsy, Mood Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: SungKyunKwan University, BK21 FOUR, Ministry of Education.
Abstract (Originalsprache)
Objective
Epilepsy is a globally prevalent neurological condition associated with mood disorders such as depression and bipolar disorder. This study analyzed the prevalence of and hazard ratios for mood disorders, as well as risk factors, among patients with newly diagnosed epilepsy using a comprehensive South Korean national health database.
Method
Health insurance and health examination data (2004-2013) were utilized in this retrospective cohort study. Patients newly diagnosed with epilepsy based on International Classification of Diseases-10th revision codes and without a mood disorder history were included. Mean follow-up duration was 3.6 years and 4.1 years for the epilepsy and control cohorts, respectively. Cox proportional hazards models adjusted for demographic and health variables were used to estimate the risk of developing mood disorders post-epilepsy diagnosis.
Results
A total of 2210 patients with epilepsy and 22,100 matched controls without epilepsy were included. Those with epilepsy exhibited a 3-fold increased risk of developing mood disorders compared with controls (incidence rate ratio: 3.10 [95% confidence interval (CI): 2.75-3.49]). The risk was highest in the first two years post-diagnosis (adjusted hazard ratio: 3.42 [95% CI: 2.90-4.03]). A notable increase in risk was also observed 8-10 years post-diagnosis (adjusted hazard ratio: 3.07 [(95% CI: 1.14-8.22]), indicating a sustained long-term risk.
Conclusions
Epilepsy significantly increases the risk of mood disorders, with the highest risk observed shortly after diagnosis. Continuous monitoring and tailored interventions are essential for managing patients’ mental health. Integrated care approaches are needed to treat epilepsy and associated mood disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Korean Armed Forces Capital Hospital, Seongnam, Republic of Korea.
- Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
- Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Statistics, Sungshin Women's University, Seoul, Republic of Korea.
- Data Science Center, Sungshin Women's University, Seoul, Republic of Korea.
- Personalized Cancer Immunotherapy Research Center, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
ORCID-Profile: Hohyun Jung
Förderung
- SungKyunKwan University
- BK21 FOUR
- Ministry of Education
- National Research Foundation of Korea
- Korean government
Zitieren
APA
Bae, Y., Kang, C., Choi, U., Jung, H., & Lee, S. W. (2025). Risk of mood disorders after epilepsy diagnosis: A nationwide retrospective cohort study in South Korea. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/00912174251336045
Vancouver
Bae Y, Kang C, Choi U, Jung H, Lee SW. Risk of mood disorders after epilepsy diagnosis: A nationwide retrospective cohort study in South Korea. The International Journal of Psychiatry in Medicine. 2025. doi:10.1177/00912174251336045
BibTeX
@article{Bae2025,
author = {Bae, Youngoh and Kang, Chaeyoon and Choi, Unbi and Jung, Hohyun and Lee, Seung Won},
title = {Risk of mood disorders after epilepsy diagnosis: A nationwide retrospective cohort study in South Korea},
journal = {The International Journal of Psychiatry in Medicine},
year = {2025},
doi = {10.1177/00912174251336045}
}
EUVIMED